Japan Post-Marketing Surveillance for Peficitinib to Assess Safety and Effectiveness in the Patients With Rheumatoid Arthritis | MicrobiomeTrials← Back to trialsNCT03971253
Japan Post-Marketing Surveillance for Peficitinib to Assess Safety and Effectiveness in the Patients With Rheumatoid Arthritis
CompletedOBSERVATIONAL
Trial Details
Start: 2019-09-02Est. Completion: 2026-05-29
Enrollment target: 3,000 participants Locations- Site JP00023, Aichi, Japan
- Site JP00005, Akita, Japan
- Site JP00002, Aomori, Japan
- Site JP00012, Chiba, Japan
- Site JP00038, Ehime, Japan
- Site JP00018, Fukui, Japan
- Site JP00040, Fukuoka, Japan
- Site JP00007, Fukushima, Japan
- Site JP00021, Gifu, Japan
- Site JP00010, Gunma, Japan
- Site JP00034, Hiroshima, Japan
- Site JP00001, Hokkaido, Japan
- Site JP00028, Hyōgo, Japan
- Site JP00008, Ibaraki, Japan
- Site JP00017, Ishikawa, Japan
- Site JP00037, Kagawa, Japan
- Site JP00046, Kagoshima, Japan
- Site JP00014, Kanagawa, Japan
- Site JP00039, Kochi, Japan
- Site JP00043, Kumamoto, Japan
- Site JP00026, Kyoto, Japan
- Site JP00024, Mie, Japan
- Site JP00004, Miyagi, Japan
- Site JP00045, Miyazaki, Japan
- Site JP00020, Nagano, Japan
- Site JP00042, Nagasaki, Japan
- Site JP00029, Nara, Japan
- Site JP00015, Niigata, Japan
- Site JP00003, Numakunai, Japan
- Site JP00033, Okayama, Japan
- Site JP00047, Okinawa, Japan
- Site JP00027, Osaka, Japan
- Site JP00044, Ōita, Japan
- Site JP00041, Saga, Japan
- Site JP00011, Saitama, Japan
- Site JP00025, Shiga, Japan
- Site JP00032, Shimane, Japan
- Site JP00022, Shizuoka, Japan
- Site JP00009, Tochigi, Japan
- Site JP00036, Tokushima, Japan
Other microbiome trials you might be interested in
Rheumatoid Arthritis (RA)Systemic Lupus Erythematosus (SLE)Pemphigus VulgarisMultiple Sclerosis (MS)Systemic Sclerosis (SSc)Pediatric SLEJuvenile Idiopathic Arthritis (JIA)Juvenile Dermatomyositis (JDM)Pediatric-Onset Multiple Sclerosis (POMS)
This is a randomized, multi-site, adaptive, open-label clinical trial comparing the immune response to different additio…
Los Angeles, United StatesCompleted Jun 22, 2023
Site JP00013, Tokyo, JapanSite JP00031, Tottori, JapanSite JP00016, Toyama, JapanSite JP00030, Wakayama, JapanSite JP00006, Yamagata, JapanSite JP00035, Yamaguchi, JapanSite JP00019, Yamanashi, JapanRheumatoid Arthritis (RA)Ankylosing Spondylitis (AS)Forward Head Posture
The purpose of this cross-sectional and comparative study is to investigate the impact of smartphone addiction on the ce…
Konya, Turkey (Türkiye)Est. completion Nov 2026